Strides Pharma Science Ltd - 532531 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Strides Pharma Science will engage with analysts and institutional investors in a Non-Deal Road Show hosted by DAM Capital on June 12, 2026. The meeting will be in-person in Mumbai.
Jun 08 2026 20:15:52
Strides Pharma Science Ltd - 532531 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Strides Pharma Science will conduct non-deal investor roadshows in New York, Chicago, Salt Lake City, and Los Angeles from June 2-5, 2026. These one-on-one meetings will utilize the Q4 FY26 earnings presentation as the discussion document for institutional investors.
May 28 2026 20:11:00
Strides Pharma Science Ltd - 532531 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Strides Pharma Science is scheduled to participate in a Non-Deal Road Show in the USA from June 2 to June 5, 2026. The company will conduct in-person one-on-one meetings with analysts and institutional investors across four cities: New York, Chicago, Salt Lake City, and Los Angeles. The discussions will include the Q4 FY26 earnings presentation.
May 28 2026 20:07:31
Strides Pharma Science Ltd - 532531 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Strides Pharma Science is scheduled to participate in a Non-Deal Road Show in the USA from June 2 to June 5, 2026. The company will conduct in-person one-on-one meetings with analysts and institutional investors across four cities: New York, Chicago, Salt Lake City, and Los Angeles. The discussions will include the Q4 FY26 earnings presentation.
May 28 2026 20:05:01
Strides Pharma Science Ltd - 532531 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Strides Pharma Science is scheduled to participate in a Non-Deal Road Show in the USA from June 2 to June 5, 2026. The company will conduct in-person one-on-one meetings with analysts and institutional investors across four cities: New York, Chicago, Salt Lake City, and Los Angeles. The discussions will include the Q4 FY26 earnings presentation.
May 28 2026 20:01:45
Read More